Sanara Medtech Return On Equity vs. Return On Asset
| SMTI Stock | USD 36.34 0.22 0.60% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.1) | Current Value (0.10) | Quarterly Volatility 1.47015486 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.92 | 0.8792 |
|
|
For Sanara Medtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sanara Medtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sanara Medtech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sanara Medtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sanara Medtech over time as well as its relative position and ranking within its peers.
Sanara |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 9.241 | Quarterly Revenue Growth 0.352 | Return On Assets (0.05) | Return On Equity (0.20) |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sanara Medtech Return On Asset vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sanara Medtech's current stock value. Our valuation model uses many indicators to compare Sanara Medtech value to that of its competitors to determine the firm's financial worth. Sanara Medtech is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Sanara Medtech's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sanara Medtech's earnings, one of the primary drivers of an investment's value.Sanara Return On Asset vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Sanara Medtech |
| = | -0.2 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Sanara Medtech |
| = | -0.0508 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Sanara Return On Asset Comparison
Sanara Medtech is currently under evaluation in return on asset category among its peers.
Sanara Medtech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sanara Medtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sanara Medtech will eventually generate negative long term returns. The profitability progress is the general direction of Sanara Medtech's change in net profit over the period of time. It can combine multiple indicators of Sanara Medtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -4.2 M | -4.4 M | |
| Income Before Tax | -4.4 M | -4.7 M | |
| Total Other Income Expense Net | -224.7 K | -236 K | |
| Net Loss | -4.3 M | -4.5 M | |
| Income Tax Expense | -136.7 K | -129.9 K | |
| Net Loss | -8.3 M | -7.9 M | |
| Net Loss | -7.1 M | -6.8 M | |
| Net Interest Income | -473 K | -449.4 K | |
| Non Operating Income Net Other | -1.5 M | -1.5 M | |
| Change To Netincome | -731.4 K | -694.8 K | |
| Net Loss | (0.52) | (0.55) | |
| Income Quality | 0.75 | 0.79 | |
| Net Income Per E B T | 0.97 | 0.59 |
Sanara Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sanara Medtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sanara Medtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sanara Medtech's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Sanara Medtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Use Investing Themes to Complement your Sanara Medtech position
In addition to having Sanara Medtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project Sanara Medtech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sanara Medtech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sanara Medtech's income statement, its balance sheet, and the statement of cash flows.